William S. Baldwin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
William S. Baldwin has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
Elizabeth J. Litoff
Biological Sciences, Clemson University, Clemson, SC 29634, United States
5 shared publications- Linda C. Mota
Environmental Toxicology, Clemson University, Pendleton, SC, United States of America
5 shared publications Gautam K. Ginjupalli
Environmental Toxicology Program, Clemson University, Clemson, South Carolina
4 shared publications- Jazmine A. Eccles
Clemson University
4 shared publications Juan P. Hernandez
Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America
4 shared publicationsNamrata Sengupta
Environmental Toxicology Program, Clemson University, Clemson, SC, USA
4 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by Elsevier in Chemosphere
- Vol. 394, 144815
Perfluorooctane sulfonic acid (PFOS) perturbs skeletal muscle oxidative phosphorylation by a different mechanism than liver
- 30 December 2025
- Published by Elsevier in Chemosphere
- Vol. 394, 144815
Open AccessPerfluorooctane sulfonic acid (PFOS) perturbs skeletal muscle oxidative phosphorylation by a different mechanism than liver
- Open Access
Mixtures of p,p′-DDE, PCB153, BDE47, and PFOS Alter Adipocytic Differentiation of 3T3-L1 Cells
Exposure to certain chemicals can promote adipogenesis, but less is known about whether exposure to human-relevant chemical mixtures behaves similarly. Chemical concentrations from the serum of mothers enrolled in the Environmental Influences on Child Health Outcomes—Fetal Growth Study (n = 813) were used in a self-organizing map algorithm to identify five distinct patterns of real-world exposure mixtures containing p,p′-DDE, PCB153, BDE47, and PFOS. Each mixture profile was exposed to 3T3-L1 cells at 1×, 50×, and 500× serum levels over a 14-day adipogenic differentiation period. Cells were assessed for triglycerides and markers of adipocyte formation and maturation. The results indicate that a mixture dominated by high BDE47 levels (Profile 3) behaved differently than BDE47 alone. BDE47 alone increased expression of Fsp27, Fabp4, and Cpt1, while the Profile 3 mixture inhibited expression of these three genes. In contrast, mixtures dominated by either p,p′-DDE or PFOS (Profiles 1 and 4) behaved similarly to their dominant chemicals. Exposures inducing Pparγ increased Fsp27 levels, while those inducing Ampk reduced Fsp27 levels. These findings suggest that individual chemicals alter transcription factors that control adipogenesis, and the interplay between transcription factors yields synergistic or antagonistic chemical interactions in real-world mixture exposures.
Open AccessMixtures of p,p′-DDE, PCB153, BDE47, and PFOS Alter Adipocytic Differentiation of 3T3-L1 Cells
Exposure to certain chemicals can promote adipogenesis, but less is known about whether exposure to human-relevant chemical mixtures behaves similarly. Chemical concentrations from the serum of mothers enrolled in the Environmental Influences on Child Health Outcomes—Fetal Growth Study (n = 813) were used in a self-organizing map algorithm to identify five distinct patterns of real-world exposure mixtures containing p,p′-DDE, PCB153, BDE47, and PFOS. Each mixture profile was exposed to 3T3-L1 cells at 1×, 50×, and 500× serum levels over a 14-day adipogenic differentiation period. Cells were assessed for triglycerides and markers of adipocyte formation and maturation. The results indicate that a mixture dominated by high BDE47 levels (Profile 3) behaved differently than BDE47 alone. BDE47 alone increased expression of Fsp27, Fabp4, and Cpt1, while the Profile 3 mixture inhibited expression of these three genes. In contrast, mixtures dominated by either p,p′-DDE or PFOS (Profiles 1 and 4) behaved similarly to their dominant chemicals. Exposures inducing Pparγ increased Fsp27 levels, while those inducing Ampk reduced Fsp27 levels. These findings suggest that individual chemicals alter transcription factors that control adipogenesis, and the interplay between transcription factors yields synergistic or antagonistic chemical interactions in real-world mixture exposures.
- Open Access
Toxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF)
Poly- and perfluorinated alkyl substances (PFAS) are a group of chemicals that are widely used, prevalent in the environment, associated with several toxic effects, and often have long half-lives. Their persistence and relevant toxicity are the primary causes of environmental and human health concerns, and they are referred to as “forever chemicals” because of their persistence. Environmental accumulation caused by slow natural biodegradation and subsequent long environmental half-lives leads to bioaccumulation and makes PFAS more likely to be chronically toxic with potential transgenerational effects. Ultimately, it is this persistence that causes the greatest concern because PFAS-contaminated sites need costly remediation techniques, or else the contaminated areas will not be available for proper economic development because of social and economic suppression. Non-PFAS, alternative Aqueous Film Forming Foams (AFFF) that are considered environmentally friendly, are being heavily considered or currently used for fire suppression instead of PFAS-based products. The bioaccumulation and toxicity of alternative AFFF are just starting to be studied. The purpose of this review is to discuss the basic environmental and human health effects of PFAS and alternative AFFF that propel regulatory changes, increase clean-up costs, reduce economic development, and drive the development of novel alternatives.
Open AccessToxicological, Chemical, Social, and Economic Challenges Associated with PFAS and Replacement Aqueous Film-Forming Foams (AFFF)
Poly- and perfluorinated alkyl substances (PFAS) are a group of chemicals that are widely used, prevalent in the environment, associated with several toxic effects, and often have long half-lives. Their persistence and relevant toxicity are the primary causes of environmental and human health concerns, and they are referred to as “forever chemicals” because of their persistence. Environmental accumulation caused by slow natural biodegradation and subsequent long environmental half-lives leads to bioaccumulation and makes PFAS more likely to be chronically toxic with potential transgenerational effects. Ultimately, it is this persistence that causes the greatest concern because PFAS-contaminated sites need costly remediation techniques, or else the contaminated areas will not be available for proper economic development because of social and economic suppression. Non-PFAS, alternative Aqueous Film Forming Foams (AFFF) that are considered environmentally friendly, are being heavily considered or currently used for fire suppression instead of PFAS-based products. The bioaccumulation and toxicity of alternative AFFF are just starting to be studied. The purpose of this review is to discuss the basic environmental and human health effects of PFAS and alternative AFFF that propel regulatory changes, increase clean-up costs, reduce economic development, and drive the development of novel alternatives.
- Open Access
- 25 January 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 295
Sexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE
Background: Cytochrome P450 2B6 (CYP2B6) is a sexually dimorphic, anti-obesity CYP enzyme responsible for the metabolism of xeno- and endobiotics, including the metabolism of polyunsaturated fatty acids (PUFAs) into 9-hydroxyoctadecadienoic acid (9-HODE) and 9-hydroxyoctadecatrienoic acid (9-HOTrE). However, humanized CYP2B6 transgenic (hCYP2B6-Tg) mice are sensitive to diet-induced hepatic steatosis despite their resistance to obesity. The purpose of this study was to determine if 9-HODE, 9-HOTrE, or other factors contribute to the sexually dimorphic steatosis observed in hCYP2B6-Tg mice. Results: Cyp2b9/10/13-null (Cyp2b-null) mice were injected with either 9-HODE or 9-HOTrE for 2 days and were then subjected to a fasting period of 20 h to induce steatosis. Serum lipids were moderately increased, especially in females, after 9-HODE (triglycerides (TGs), very low-density lipoproteins (VLDLs)) and 9-HOTrE (high-density lipoproteins (HDLs), low-density lipoproteins (LDLs), cholesterol) treatment. No change in hepatic lipids and few changes in hepatic gene expression were observed in mice treated with either oxylipin, suggesting that these oxylipins had minimal to moderate effects. Therefore, to further investigate CYP2B6’s role in steatosis, hCYP2B6-Tg and Cyp2b-null mice were subjected to a 20 h fast and compared. Both male and female hCYP2B6-Tg mice exhibited increased steatosis compared to Cyp2b-null mice. Serum cholesterol, triglycerides, HDLs, and VLDLs were increased in hCYP2B6-Tg males. Serum triglycerides and VLDLs were decreased in hCYP2B6-Tg females, suggesting the greater hepatic retention of lipids in females. Hepatic oxylipin profiles revealed eight perturbed oxylipins in female hCYP2B6-Tg mice and only one in males when compared to Cyp2b-null mice. RNA-seq also demonstrated greater effects in females in terms of the number of genes and gene ontology (GO) terms perturbed. There were only a few overlapping GO terms between sexes, and lipid metabolic processes were enriched in hCYP2B6-Tg male mice but were repressed in hCYP2B6-Tg females compared to Cyp2b-nulls. Conclusions: hCYP2B6-Tg mice are sensitive to fasting-mediated steatosis in males and females, although the responses are different. In addition, the oxylipins 9-HODE and 9-HOTrE are unlikely to be the primary cause of CYP2B6’s pro-steatotic effects.
- 25 January 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 295
Open AccessSexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE
Background: Cytochrome P450 2B6 (CYP2B6) is a sexually dimorphic, anti-obesity CYP enzyme responsible for the metabolism of xeno- and endobiotics, including the metabolism of polyunsaturated fatty acids (PUFAs) into 9-hydroxyoctadecadienoic acid (9-HODE) and 9-hydroxyoctadecatrienoic acid (9-HOTrE). However, humanized CYP2B6 transgenic (hCYP2B6-Tg) mice are sensitive to diet-induced hepatic steatosis despite their resistance to obesity. The purpose of this study was to determine if 9-HODE, 9-HOTrE, or other factors contribute to the sexually dimorphic steatosis observed in hCYP2B6-Tg mice. Results: Cyp2b9/10/13-null (Cyp2b-null) mice were injected with either 9-HODE or 9-HOTrE for 2 days and were then subjected to a fasting period of 20 h to induce steatosis. Serum lipids were moderately increased, especially in females, after 9-HODE (triglycerides (TGs), very low-density lipoproteins (VLDLs)) and 9-HOTrE (high-density lipoproteins (HDLs), low-density lipoproteins (LDLs), cholesterol) treatment. No change in hepatic lipids and few changes in hepatic gene expression were observed in mice treated with either oxylipin, suggesting that these oxylipins had minimal to moderate effects. Therefore, to further investigate CYP2B6’s role in steatosis, hCYP2B6-Tg and Cyp2b-null mice were subjected to a 20 h fast and compared. Both male and female hCYP2B6-Tg mice exhibited increased steatosis compared to Cyp2b-null mice. Serum cholesterol, triglycerides, HDLs, and VLDLs were increased in hCYP2B6-Tg males. Serum triglycerides and VLDLs were decreased in hCYP2B6-Tg females, suggesting the greater hepatic retention of lipids in females. Hepatic oxylipin profiles revealed eight perturbed oxylipins in female hCYP2B6-Tg mice and only one in males when compared to Cyp2b-null mice. RNA-seq also demonstrated greater effects in females in terms of the number of genes and gene ontology (GO) terms perturbed. There were only a few overlapping GO terms between sexes, and lipid metabolic processes were enriched in hCYP2B6-Tg male mice but were repressed in hCYP2B6-Tg females compared to Cyp2b-nulls. Conclusions: hCYP2B6-Tg mice are sensitive to fasting-mediated steatosis in males and females, although the responses are different. In addition, the oxylipins 9-HODE and 9-HOTrE are unlikely to be the primary cause of CYP2B6’s pro-steatotic effects.
- Open Access
Closing the Gaps in Understanding PFAS Toxicology and Metabolism
Per- and polyfluoroalkyl substances (PFAS) are nearly ubiquitous and found in rivers, soils, atmosphere, food packaging, clothing, cosmetics, commercial products, homes, drinking water, and humans and other organisms
Open AccessClosing the Gaps in Understanding PFAS Toxicology and Metabolism
Per- and polyfluoroalkyl substances (PFAS) are nearly ubiquitous and found in rivers, soils, atmosphere, food packaging, clothing, cosmetics, commercial products, homes, drinking water, and humans and other organisms
- Open Access
Increased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression
Perfluorooctanesulfonate (PFOS) is a widespread environmental pollutant with a long half-life and clearly negative outcomes on metabolic diseases such as fatty liver disease and diabetes. Male and female Cyp2b-null and humanized CYP2B6-transgenic (hCYP2B6-Tg) mice were treated with 0, 1, or 10 mg/kg/day PFOS for 21 days, and surprisingly it was found that PFOS was retained at greater concentrations in the serum and liver of hCYP2B6-Tg mice than those of Cyp2b-null mice, with greater differences in the females. Thus, Cyp2b-null and hCYP2B6-Tg mice provide new models for investigating individual mechanisms for PFOS bioaccumulation and toxicity. Overt toxicity was greater in hCYP2B6-Tg mice (especially females) as measured by mortality; however, steatosis occurred more readily in Cyp2b-null mice despite the lower PFOS liver concentrations. Targeted lipidomics and transcriptomics from PFOS-treated Cyp2b-null and hCYP2B6-Tg mouse livers were performed and compared to PFOS retention and serum markers of toxicity using PCA. Several oxylipins, including prostaglandins, thromboxanes, and docosahexaenoic acid metabolites, are associated or inversely associated with PFOS toxicity. Both lipidomics and transcriptomics indicate PFOS toxicity is associated with PPAR activity in all models. GO terms associated with reduced steatosis were sexually dimorphic with lipid metabolism and transport increased in females and circadian rhythm associated genes increased in males. However, we cannot rule out that steatosis was initially protective from PFOS toxicity. Moreover, several transporters are associated with increased retention, probably due to increased uptake. The strongest associations are the organic anion transport proteins (Oatp1a4-6) genes and a long-chain fatty acid transport protein (fatp1), enriched in female hCYP2B6-Tg mice. PFOS uptake was also reduced in cultured murine hepatocytes by OATP inhibitors. The role of OATP1A6 and FATP1 in PFOS transport has not been tested. In summary, Cyp2b-null and hCYP2B6-Tg mice provided unique models for estimating the importance of novel mechanisms in PFOS retention and toxicity.
Open AccessIncreased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression
Perfluorooctanesulfonate (PFOS) is a widespread environmental pollutant with a long half-life and clearly negative outcomes on metabolic diseases such as fatty liver disease and diabetes. Male and female Cyp2b-null and humanized CYP2B6-transgenic (hCYP2B6-Tg) mice were treated with 0, 1, or 10 mg/kg/day PFOS for 21 days, and surprisingly it was found that PFOS was retained at greater concentrations in the serum and liver of hCYP2B6-Tg mice than those of Cyp2b-null mice, with greater differences in the females. Thus, Cyp2b-null and hCYP2B6-Tg mice provide new models for investigating individual mechanisms for PFOS bioaccumulation and toxicity. Overt toxicity was greater in hCYP2B6-Tg mice (especially females) as measured by mortality; however, steatosis occurred more readily in Cyp2b-null mice despite the lower PFOS liver concentrations. Targeted lipidomics and transcriptomics from PFOS-treated Cyp2b-null and hCYP2B6-Tg mouse livers were performed and compared to PFOS retention and serum markers of toxicity using PCA. Several oxylipins, including prostaglandins, thromboxanes, and docosahexaenoic acid metabolites, are associated or inversely associated with PFOS toxicity. Both lipidomics and transcriptomics indicate PFOS toxicity is associated with PPAR activity in all models. GO terms associated with reduced steatosis were sexually dimorphic with lipid metabolism and transport increased in females and circadian rhythm associated genes increased in males. However, we cannot rule out that steatosis was initially protective from PFOS toxicity. Moreover, several transporters are associated with increased retention, probably due to increased uptake. The strongest associations are the organic anion transport proteins (Oatp1a4-6) genes and a long-chain fatty acid transport protein (fatp1), enriched in female hCYP2B6-Tg mice. PFOS uptake was also reduced in cultured murine hepatocytes by OATP inhibitors. The role of OATP1A6 and FATP1 in PFOS transport has not been tested. In summary, Cyp2b-null and hCYP2B6-Tg mice provided unique models for estimating the importance of novel mechanisms in PFOS retention and toxicity.
- 8 March 2023
- Published by Springer Nature
- p. 1-28
Per- and Polyfluoroalkylsubstances (PFAS) and Their Toxicology as Evidenced Through Disease and Biomarkers
- 8 March 2023
- Published by Springer Nature
- p. 1-28
Per- and Polyfluoroalkylsubstances (PFAS) and Their Toxicology as Evidenced Through Disease and Biomarkers
- 1 February 2023
- Published by Springer Nature
- p. 989-1016
Per- and Polyfluoroalkyl Substances (PFAS) and Their Toxicology as Evidenced Through Disease and Biomarkers
- 1 February 2023
- Published by Springer Nature
- p. 989-1016
Per- and Polyfluoroalkyl Substances (PFAS) and Their Toxicology as Evidenced Through Disease and Biomarkers
- Open Access
Detoxification Cytochrome P450s (CYPs) in Families 1–3 Produce Functional Oxylipins from Polyunsaturated Fatty Acids
This manuscript reviews the CYP-mediated production of oxylipins and the current known function of these diverse set of oxylipins with emphasis on the detoxification CYPs in families 1–3. Our knowledge of oxylipin function has greatly increased over the past 3–7 years with new theories on stability and function. This includes a significant amount of new information on oxylipins produced from linoleic acid (LA) and the omega-3 PUFA-derived oxylipins such as α-linolenic acid (ALA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA). However, there is still a lack of knowledge regarding the primary CYP responsible for producing specific oxylipins, and a lack of mechanistic insight for some clinical associations between outcomes and oxylipin levels. In addition, the role of CYPs in the production of oxylipins as signaling molecules for obesity, energy utilization, and development have increased greatly with potential interactions between diet, endocrinology, and pharmacology/toxicology due to nuclear receptor mediated CYP induction, CYP inhibition, and receptor interactions/crosstalk. The potential for diet-diet and diet-drug/chemical interactions is high given that these promiscuous CYPs metabolize a plethora of different endogenous and exogenous chemicals.
Open AccessDetoxification Cytochrome P450s (CYPs) in Families 1–3 Produce Functional Oxylipins from Polyunsaturated Fatty Acids
This manuscript reviews the CYP-mediated production of oxylipins and the current known function of these diverse set of oxylipins with emphasis on the detoxification CYPs in families 1–3. Our knowledge of oxylipin function has greatly increased over the past 3–7 years with new theories on stability and function. This includes a significant amount of new information on oxylipins produced from linoleic acid (LA) and the omega-3 PUFA-derived oxylipins such as α-linolenic acid (ALA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA). However, there is still a lack of knowledge regarding the primary CYP responsible for producing specific oxylipins, and a lack of mechanistic insight for some clinical associations between outcomes and oxylipin levels. In addition, the role of CYPs in the production of oxylipins as signaling molecules for obesity, energy utilization, and development have increased greatly with potential interactions between diet, endocrinology, and pharmacology/toxicology due to nuclear receptor mediated CYP induction, CYP inhibition, and receptor interactions/crosstalk. The potential for diet-diet and diet-drug/chemical interactions is high given that these promiscuous CYPs metabolize a plethora of different endogenous and exogenous chemicals.